The COVID-19 pandemic is affecting each of us and our communities in different ways. Through this unprecedented and evolving crisis, our more than 30,000 employees have never stopped working for patients, have demonstrated incredible resolve and support for one another, and have contributed meaningfully to global relief efforts.

As we advance planning efforts to bring our remote workforce back to our 250+ sites around the world and into the field, we are being guided by the following core principles:

• Serving the Needs of our Patients and Customers
• Prioritizing Health and Safety
• Following Medical Advice and Government Direction
• Leading with Compassion and Flexibility
• Modeling Key Learnings

Read more on our principles here

No single approach will fit for every site or market. Throughout our planning, we will maintain our steadfast commitment to protecting the health and safety of our workforce and our communities while ensuring uninterrupted supply of medicines to patients and building on our competitive advantage.

We are prepared to do this in a thoughtful and phased approach, recognizing that timelines and circumstances will vary across the globe. In fact, we have a number of sites, including in China, South Korea, Taiwan, and Israel that have already begun this process. We are learning valuable lessons on being nimble and collaborating in new ways, and this experience will drive us to become an even stronger and more resilient organization.

As a responsible global citizen, we are committed to supporting communities deeply affected by the virus and will take all necessary actions to promote public health and carry out our mission of providing life-saving medicines to the patients who depend on us.

Read more on our response here.

Giovanni Caforio, M.D., Chairman and CEO